Innate Pharma's anti-cancer platform attracts BMS investment
Interviewee/Contributor
Herve Brailly
Organisation
Innate Pharma SA
Research Directory
How Innate Pharma turned a threat into an opportunity
Interviewee/ContributorHerve BraillyOrganisationInnate Pharma SA